European journal of radiology · 2025
Superselective embolization of the medial calcaneal artery: a minimally invasive and novel solution for rapid pain relief in plantar fasciitis.
Clinical StudyСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tonkaz Mehmet, Bekci Tumay
Аннотация
PURPOSE: This study evaluated the efficacy and safety of superselective embolization of the medial calcaneal artery using imipenem/cilastatin in patients with chronic, treatment-resistant plantar fasciitis.
MATERIALS AND METHODS: In this single-center prospective study, 32 patients (17 females, 15 males; mean age: 47.3 ± 9.1 years) with chronic plantar fasciitis unresponsive to conservative treatments underwent superselective embolization of the medial calcaneal artery using imipenem/cilastatin. In 31 patients (96.9 %), the target artery originated from the posterior tibial artery or lateral plantar artery; in one patient (3.1 %), it originated from the peroneal artery due to anatomical variations. Pain severity was assessed using the Visual Analog Scale (VAS), functional status with the Foot Function Index (FFI), and plantar fascia thickness using ultrasound imaging. Technical success, complications, and recurrence were recorded.
RESULTS: All procedures were technically successful, with no major or minor complications. The mean VAS score decreased from 7.3 ± 0.7 at baseline to 1.3 ± 0.5 at six months (p < 0.001), while the mean FFI score improved from 55.5 ± 4.9 to 20.4 ± 6.3 (p < 0.001). Plantar fascia thickness decreased from 5.2 ± 0.6 mm to 3.7 ± 0.3 mm at six months (p < 0.001). Minimal recurrence was observed in five patients (15.6 %) with physically demanding occupations and orthopedic heel insoles were recommended; however, no repeat embolization was required.
CONCLUSION: Superselective embolization of the medial calcaneal artery using imipenem/cilastatin represents a novel, safe, and minimally invasive strategy for rapid and sustained pain relief in patients with chronic plantar fasciitis.
MATERIALS AND METHODS: In this single-center prospective study, 32 patients (17 females, 15 males; mean age: 47.3 ± 9.1 years) with chronic plantar fasciitis unresponsive to conservative treatments underwent superselective embolization of the medial calcaneal artery using imipenem/cilastatin. In 31 patients (96.9 %), the target artery originated from the posterior tibial artery or lateral plantar artery; in one patient (3.1 %), it originated from the peroneal artery due to anatomical variations. Pain severity was assessed using the Visual Analog Scale (VAS), functional status with the Foot Function Index (FFI), and plantar fascia thickness using ultrasound imaging. Technical success, complications, and recurrence were recorded.
RESULTS: All procedures were technically successful, with no major or minor complications. The mean VAS score decreased from 7.3 ± 0.7 at baseline to 1.3 ± 0.5 at six months (p < 0.001), while the mean FFI score improved from 55.5 ± 4.9 to 20.4 ± 6.3 (p < 0.001). Plantar fascia thickness decreased from 5.2 ± 0.6 mm to 3.7 ± 0.3 mm at six months (p < 0.001). Minimal recurrence was observed in five patients (15.6 %) with physically demanding occupations and orthopedic heel insoles were recommended; however, no repeat embolization was required.
CONCLUSION: Superselective embolization of the medial calcaneal artery using imipenem/cilastatin represents a novel, safe, and minimally invasive strategy for rapid and sustained pain relief in patients with chronic plantar fasciitis.